Home Tools
Log in
Cart

Search Result

Search Results for " mtorc2 "

20

Compounds

Cat No. Product Name Synonyms Targets
T35343 MTI-31 MTI-31,LXI-15029 mTOR
MTI-31 (LXI-15029) is a potent, orally active and highly selective inhibitor of mTORC1 and mTORC2. MTI-31 is selective for mTOR (Kd: 0.20 nM) versus PIK3CA, PIK3CB and PIK3G with >5,000 fold selectivity in mTOR binding a...
T11728 JR-AB2-011 mTOR
JR-AB2-011 is a selective mTORC2 inhibitor with an IC 50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association ( K i : 0.19 μM) and is cytotoxic in glioblastoma [1].
T2475 KU-0063794 mTOR
KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2.
T6319 OSI-027 ASP4786,OSI027 DNA-PK , PI3K , mTOR , Autophagy
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK. Phase 1.
T12123 MTOR inhibitor-3 mTOR
mTOR inhibitor-3 is a selective mTOR inhibitor (Ki= 1.5 nM). mTOR inhibitor-3 inhibits mTORC1 and mTORC2 in cellular and in vivo experiments.
T9156 CDC25B-IN-2 Phosphatase , mTOR
BIA is an inhibitor of the interaction between TMBIM6 and mTORC2, which ultimately blocks AKT activation and cancer progression.
T8649 TMBIM6 antagonist-1 BAX-inhibitor-1,BIA mTOR
TMBIM6 antagonist-1 (BAX-inhibitor-1) is a bax inhibitor
T36200 AZD 3147 mTOR
AZD 3147 is an inhibitor of mTORC with IC50s of 40.7 and 5.75 nM for mTORC1 and mTORC2. AZD 3147 shows IC50s of 912, 5495, 9333, and 6310 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively.
T14552 Dactolisib Tosylate BEZ235 Tosylate,NVP-BEZ 235 Tosylate PI3K , mTOR
Dactolisib Tosylate (BEZ235 Tosylate) is a dual kinase inhibitor that targets PI3K and mTOR. dactolisib Tosylate exhibits IC50 values of 4, 75, 7, and 5 nM for PI3Kα, β, γ, and δ, respectively. dactolisib Tosylate inhibi...
T6732 WYE-687 p38 MAPK , PI3K , Src , mTOR
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(T308). Selectivity for mTOR is greater than PI3Kα (>100-fol...
T6731 WYE-354 Apoptosis , PI3K , mTOR , Autophagy
WYE-354(IC50=5 nM) is an effective, selective and ATP-competitive mTOR inhibitor. It blocks mTORC2/P-AKT(S473) and mTORC1/P-S6K(T389), not P-AKT(T308). The selectivity for mTOR is higher than PI3Kα (>100-fold) and PI3Kγ ...
T6730 WAY-600 WAY600 VEGFR , PI3K , Src , mTOR
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold...
T3514 CZ415 mTOR
CZ415 is a potent and highly selective mTOR inhibitor.
T2414 Torkinib PP 242 Apoptosis , Mitophagy , PI3K , mTOR , Autophagy
Torkinib (PP 242) (PP 242) is a selective and ATP-competitive mTOR inhibitor (IC50: 8 nM). It also inhibits mTORC1/2 (IC50s: 30/58 nM).
T3541 CC-115 CC 115 DNA-PK , PI3K , mTOR
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM).
T1961 Vistusertib AZD2014 Apoptosis , Akt , PI3K , S6 Kinase , mTOR , Autophagy
Vistusertib (AZD2014) is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
T6103 VS-5584 SB2343,VS 5584,VS5584 PI3K , mTOR
VS-5584 (SB2343) is a pan-PI3K/mTOR kinase inhibitor.
T6030 XL388 P450 , PI3K , mTOR
XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases.
T2706 Palomid 529 P529,SG 00529 Apoptosis , mTOR
Palomid 529 (SG 00529) has been used in trials studying the treatment of Age-Related Macular Degeneration.
T1859 AZD-8055 Apoptosis , mTOR , Autophagy
AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.
1 2 3
TargetMol